These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 38493719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bryodulcosigenin attenuates bleomycin-induced pulmonary fibrosis via inhibiting AMPK-mediated mesenchymal epithelial transition and oxidative stress.
    Ding Y, Wang L, Liu B, Ren G, Okubo R, Yu J, Zhang C.
    Phytother Res; 2022 Oct; 36(10):3911-3923. PubMed ID: 35794782
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D, Shen L.
    Sci Rep; 2016 Oct 24; 6():35696. PubMed ID: 27774992
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation.
    Shi W, Hao J, Wu Y, Liu C, Shimizu K, Li R, Zhang C.
    Eur J Pharmacol; 2022 Apr 15; 921():174825. PubMed ID: 35283110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
    Chen X, Shi C, Meng X, Zhang K, Li X, Wang C, Xiang Z, Hu K, Han X.
    Exp Mol Pathol; 2016 Aug 15; 101(1):22-30. PubMed ID: 27112840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway.
    Lu Y, Zhong W, Liu Y, Chen W, Zhang J, Zeng Z, Huang H, Qiao Y, Wan X, Meng X, Cai S, Dong H.
    Int Immunopharmacol; 2022 Mar 15; 104():108504. PubMed ID: 35026657
    [Abstract] [Full Text] [Related]

  • 11. Sinomenine attenuates pulmonary fibrosis by downregulating TGF-β1/Smad3, PI3K/Akt and NF-κB signaling pathways.
    Yao F, Xu M, Dong L, Shen X, Shen Y, Jiang Y, Zhu T, Zhang C, Yu G.
    BMC Pulm Med; 2024 May 10; 24(1):229. PubMed ID: 38730387
    [Abstract] [Full Text] [Related]

  • 12. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
    Li X, Yu H, Liang L, Bi Z, Wang Y, Gao S, Wang M, Li H, Miao Y, Deng R, Ma L, Luan J, Li S, Liu M, Lin J, Zhou H, Yang C.
    Biochem Pharmacol; 2020 Aug 10; 178():114097. PubMed ID: 32535102
    [Abstract] [Full Text] [Related]

  • 13. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F, Mou C.
    Med Sci Monit; 2020 Feb 05; 26():e919739. PubMed ID: 32019905
    [Abstract] [Full Text] [Related]

  • 14. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 05; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

  • 15. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H, Lv Z, Liu S, Zhang L, Huang K, Gao S, Gan W, Liu X, Zhang S, Helian K, Li X, Zhou H, Yang C.
    J Pharm Pharmacol; 2020 Jan 05; 72(1):44-55. PubMed ID: 31659758
    [Abstract] [Full Text] [Related]

  • 16. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y, Zhang G, Ji Y, Zhua H, Lv C, Jiang W.
    Phytomedicine; 2016 Apr 15; 23(4):350-8. PubMed ID: 27002405
    [Abstract] [Full Text] [Related]

  • 17. Salvia miltiorrhiza Bunge extract and Przewalskin ameliorate Bleomycin-induced pulmonary fibrosis by inhibition of apoptosis, oxidative stress and collagen deposition via the TGF-β1 pathway.
    Zeng M, Feng A, Ren Y, Zhang Q, Wang R, Zhang B, Liu M, Guo P, Zhang Y, Lyu J, Zheng X.
    Phytomedicine; 2024 Mar 15; 125():155339. PubMed ID: 38237513
    [Abstract] [Full Text] [Related]

  • 18. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway.
    Liu X, Shao Y, Zhang X, Ji X, Xie M, Liu H.
    Acta Histochem; 2021 Jul 15; 123(5):151746. PubMed ID: 34217047
    [Abstract] [Full Text] [Related]

  • 19. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 20. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W, Cai X, Qian Q, Zhang W, Wang D.
    J Cell Mol Med; 2018 Sep 02; 22(9):4354-4365. PubMed ID: 29971947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.